IRF-3-dependent and augmented target genes during viral infection

Genes and Immunity

Volumn 9, Issue 2, 2008, Pages 168-175

  Andersen, J ^a   VanScoy, S ^a   Cheng, T F ^a   Gomez, D ^a   Reich, N C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA INTERFERON; ATM PROTEIN; BETA INTERFERON; CHEMOKINE RECEPTOR CCR5; CXCL9 CHEMOKINE; CYTOCHROME P450; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GROWTH HORMONE RECEPTOR; HEXOKINASE; INHIBIN; INTERFERON REGULATORY FACTOR 3; LEUCINE ZIPPER PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 3; NERVE GROWTH FACTOR; PROTEASOME; PROTEIN MYB; PURINE NUCLEOSIDE PHOSPHORYLASE; RIBONUCLEASE; RNA POLYMERASE II; STAT PROTEIN; THYMIDINE KINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR; TROPOMODULIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE INDUCTION; GENE TARGETING; HOST RESISTANCE; IMMUNE RESPONSE; INFECTION RESISTANCE; INNATE IMMUNITY; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIBLING; SYSTEMS BIOLOGY; UNINDEXED SEQUENCE; VIRUS INFECTION; WILD TYPE;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENE TARGETING; IMMUNITY, NATURAL; INTERFERON REGULATORY FACTOR-3; MICE; MICE, KNOCKOUT; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 40449141669     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364449     Document Type: Article

References (51)

1. Honda K, Taniguchi T. IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev 2006; 6: 644-658.
2. Kawai T. Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7: 131-137.
3. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 2007; 282: 15325-15329.
4. Weaver BK, Kumar KP, Reich NC. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 1998; 18: 1359-1368.
5. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, Fujita T. Direct triggering of the type 1 interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/ p300. EMBO J 1998; 17: 1087-1095.
6. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1998; 1: 507-518.
7. Sato M, Tanaka N, Hata N, Oda E, Taniguchi T. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett 1998; 425: 112-116.
8. Lin R, Heylbroeck, C, Pitha PM, Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 1998; 18: 2986-2996.
9. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000; 13: 539-548.
10. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772-777.
11. Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006; 25: 349-360.
12. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491-496.
13. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003; 300: 1148-1151.
14. Kumar KP, McBride W, Weaver BK, Dingwall C, Reich NC. Regulated nuclear cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol Cell Biol 2000; 20 4159-4168.
15. Daly C, Reich NC. Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Mol Cell Biol 1993; 13: 3756-3764.
16. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons? Annu Rev Biochem 1998, 67: 227-264.
17. Levy DE, Darnell Jr JE. Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3: 651-662.
18. Sen GC. Viruses and interferons. Annu Rev Microbiol 2001; 55 255-281.
19. Stetson DB, Medzhitov R. Type I interferons in host defense. Immunity 2006; 25: 373-381.
20. Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 2000; 103: 667-678.
21. Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN et al. Transcriptional profiling of interferon regulatory factor 3 target genes: Direct involvement in the regulation of interferon-stimulated genes. J Virol 2002; 76: 5532-5539.
22. Elco CP, Guenther JM, Williams BR, Sen GC. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3. J Virol 2005; 79: 3920-3929.
23. Daly C, Reich NC. Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon alpha/beta-stimulated gene. J Biol Chem 1995; 270: 23739-23746.
24. Terenzi F, deVeer MJ, Ying H, Restifo NP, Williams BR, Silverman RH. The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors. Nucleic Acids Res 1999; 27: 4369-4375.
25. Marie I, Durbin JE, Levy DE. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998; 17: 6660-6669.
26. Moser B, Wolf M, Walz A, Loetscher P. Chemokines: Multiple levels of leukocyte migration control. Trends Immunol 2004; 25: 75-84.
27. Arenzana-Seisdedos F, Virelizier JL, Rousset D, Clark-Lewis I, Loetscher P, Moser B et al. HIV blocked by chemokine antagonist. Nature 1996; 383: 400.
28. Starling GC, Whitney GS, Siadak AW, Llewellyn MB, Bowen MA, Farr AG et al. Characterization of mouse CD6 with novel monoclonal antibodies, which enhance the allogeneic mixed leukocyte reaction. Eur J Immunol 1996, 26: 738-746.
29. Chien YH, Jores R, Crowley MP. Recognition by gamma/delta T cells. Annu Rev Immunol 1996; 14: 511-532.
30. Kambayashi T, Kraft-Leavy JR, Dauner JG, Sullivan BA, Laur O, Jensen PE. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes. J Immunol 2004; 172: 1661-1669.
31. Wang X, Johansen LM, Tae HJ, Taparowsky EJ. IFP 35 forms complexes with B-ATF, a member of the AP1 family of transcription factors. Biochem Biophys Res Commun 1996; 229: 316-322.
32. Weichenhan D, Kunze B, Zacker S, Traut W, Winking H. Structure and expression of the murine Sp100 nuclear dot gene. Genomics 1997, 43: 298-306.
33. Espert L, Degols G, Lin YL, Vincent T, Benkirane M, Mechti N. Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. J Gen Virol 2005; 86 (Part 8): 2221-2229.
34. Terenzi F, Pal S, Sen GC. Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54. Virology 2005; 340: 116-124.
35. Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci USA 2001; 98: 15125-15130.
36. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 2003; 302: 654-659.
37. Zhu H, Cong JP, Shenk T. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs. Proc Natl Acad Sci USA 1997; 94: 13985-13990.
38. Spengler D, Villalba M, Hoffmann A, Pantaloni C, Houssami S, Bockaert J el at. Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J 1997; 16 2814-2825.
39. Unoki M, Nakamura Y. EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK. Oncogene 2003; 22 2172-2185.
40. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP et al. IRE1, couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 2002; 415: 92-96.
41. Trubia M, Sessa L, Taramelli R. Mammalian Rh/T2/S-glycoprotein ribonuclease family genes: Cloning of a human member located in a region of chromosome 6 (6q27) frequently deleted in human malignancies. Genomics 1997; 42: 342-344.
42. Shiloh Y. ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 2003, 3: 155-168.
43. Monaco JJ, Nandi D. The genetics of proteasomes and antigen processing. Annu Rev Genet 1995; 29: 729-754.
44. Genin P, Algarte M, Roof P, Lin R, Hiscott J. Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J Immunol 2000; 164: 5352-5361.
45. Bluyssen HA, Vlietstra RJ, Faber PW, Smit EM, Hagemeijer A, Trapman J. Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. Genomics 1994; 24: 137-148.
46. Honda K, Yanai H, Takaoka A, Taniguchi T. Regulation of the type. I IFN induction: A current view. Int Immunol 2005; 17: 1367-1378.
47. Lee AH, Hong JH, Seo YS. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor-kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 2000; 350 (Part 1): 131-138.
48. Weaver BK, Amdo O, Kumar KP, Reich NC. Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53. FASEB J 2001; 15: 501-515.
49. Taniguchi T, Takaoka A. The interferon-alpha/beta system in antiviral responses, a multimodal, machinery, of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002, 14: 111-116.
50. Lomvardas S, Thanos D. Modifying gene expression programs by altering core promoter chromatin architecture. Cell 2002; 110: 261-271.
51. Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS et al. Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol 1998; 63: 609-620.